Immunocore Holdings (IMCR) Retained Earnings (2019 - 2025)
Immunocore Holdings (IMCR) has disclosed Retained Earnings for 7 consecutive years, with -$831.3 million as the latest value for Q4 2025.
- Quarterly Retained Earnings fell 2362.09% to -$831.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$831.3 million through Dec 2025, down 2362.09% year-over-year, with the annual reading at -$831.3 million for FY2025, 2362.09% down from the prior year.
- Retained Earnings hit -$831.3 million in Q4 2025 for Immunocore Holdings, down from -$801.2 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $520.6 million in Q4 2021 to a low of -$831.3 million in Q4 2025.
- Historically, Retained Earnings has averaged -$286.6 million across 5 years, with a median of -$36.3 million in 2023.
- Biggest five-year swings in Retained Earnings: surged 212.68% in 2021 and later tumbled 2470.22% in 2025.
- Year by year, Retained Earnings stood at $520.6 million in 2021, then crashed by 158.87% to -$306.4 million in 2022, then soared by 88.17% to -$36.3 million in 2023, then rose by 6.89% to -$33.8 million in 2024, then plummeted by 2362.09% to -$831.3 million in 2025.
- Business Quant data shows Retained Earnings for IMCR at -$831.3 million in Q4 2025, -$801.2 million in Q3 2025, and -$26.6 million in Q2 2025.